Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Fca Research Fraud topic
No spam. Unsubscribe anytime.
House Science Subcommittee examines False Claims Act as tool against grant fraud
Summary
Lawmakers and agency watchdogs debated how the False Claims Act is applied to federally funded research, focusing on undisclosed foreign support, cybersecurity certifications, whistleblower roles and whether enforcement risks chilling legitimate research or DEI programs.
The House Science, Space, and Technology Subcommittee on Investigations and Oversight held a hearing on safeguarding federal research funds and the False Claims Act (FCA), with Justice Department and agency inspector general witnesses describing enforcement priorities and oversight gaps.
DOJ’s Deputy Assistant Attorney General Brenna Jenny told the panel the FCA is a flexible civil tool that can redress a broad range of fraud in grants, contracts and loans and that whistleblowers play a central role: “These whistleblowers may be awarded 15 to 30% of the government's recovery,” she said. Jenny highlighted three research‑fraud focus areas: failure to disclose foreign funding, falsified research data or images, and cybersecurity noncompliance.
Jennifer Springmann, performing the duties of Assistant Inspector General for Investigations at the NSF Office of Inspector General, described a proactive approach that uses red flags and targeted reviews to find omissions in current and pending support disclosures. “Where proactive reviews have been valuable for us is in identifying where to focus our efforts around foreign influence,” she said, citing 15 university FCA settlements over the past decade that recovered nearly $9 million for NSF.
The NASA Office of Inspector General’s senior official reported similar priorities—developing new detection tools, tightening cybersecurity enforcement and maximizing recoveries through proactive investigations. Witnesses cited recent cyber‑related FCA settlements and said recoveries and referrals derive from a mix of whistleblower (qui tam) filings and agency referrals.
Committee members pressed witnesses on several issues: how much of DOJ’s headline $6.8 billion FY2025 recoveries came from academic research (witnesses cited specific university settlements but said no ready total was available), whether agency program officers are trained to spot red flags (NSF said program officers receive research‑security training but proactive OIG reviews are often more effective), and how subrecipient oversight and inconsistent agency forms create gaps.
The hearing also featured a contentious exchange over DOJ remarks signaling interest in cases involving unlawful discrimination tied to hiring or contracting practices. Ranking Member Sykes asked how researchers could run diversity, equity and inclusion programs without risking FCA exposure; Jenny said the department focuses on violations of long‑standing anti‑discrimination laws and cited the Federal Acquisition Regulation provision she said can form the predicate for FCA liability.
Members raised broader concerns about the timing and purpose of the hearing, recent declines in the number of NSF awards (which witnesses attributed to management and policy decisions rather than OIG action), and novel funding mechanisms such as NSF “X‑Labs” and other transactions that OIGs will need to monitor. The record remains open for 10 days for additional questions.
The committee did not vote or take formal actions at the hearing; witnesses and members agreed on the value of the FCA in recovering misspent funds while also expressing differing views on the proper scope of enforcement and the need to avoid chilling legitimate scientific collaboration.
